RecruitingPhase 1NCT07065409
Treatment of Moyamoya Disease With iPSC-derived Exosomes
Studying Moyamoya disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Huaqiu Zhang
- Principal Investigator
- Huaqiu ZhangTongji Hospital
- Intervention
- iPSC-EVs(biological)
- Enrollment
- 9 target
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2025 – 2026
Study locations (1)
- Tongji hospital, Wuhan, Hubei, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07065409 on ClinicalTrials.govOther trials for Moyamoya disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07304947Cardiac Index-Guided Intraoperative Hemodynamic Management in Pediatric Moyamoya SurgerySeoul National University Hospital
- RECRUITINGNANCT07140731The Symani Restore StudyJacobs institute
- RECRUITINGNANCT07144930Cognitive-Motor Incorporated Training and Its Relations in Cerebrovascular Diseases With Cognitive and Motor ImpairmentsNational Taiwan University Hospital
- RECRUITINGNCT06880341Managing Transient Neurologic Episodes in Surgery for Moyamoya DiseaseStanford University
- RECRUITINGNCT06832839Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya DiseaseBeijing Tiantan Hospital
- RECRUITINGNCT06817434Study on Evaluating the Effectiveness of Statins in the Treatment of Moyamoya DiseaseBeijing Tiantan Hospital
- ENROLLING BY INVITATIONNANCT06477107A Study of Cerebral Perfusion With tDCS in Chronic HypoperfusionMayo Clinic
- RECRUITINGNANCT03546309Safety and Efficacy of RIC in Pediatric Moyamoya Disease Patients Treated With Revascularization TherapyCapital Medical University